Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 2 1

Status

Unknown 5Completed 5Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Polycystic Ovary Syndrome 3Neoplasms 2Obesity 1Hyperandrogenism 1Heart Failure 1Critical Illness 1Cardiotoxicity 1Acute Kidney Injury 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × Spironolactone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

University of Virginia

Phase NA Unknown
20 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown
24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown
264 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown
24 enrolled
Genitourinary

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡